Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma

Despite the availability of new therapies that have led to improved outcomes for patients with multiple myeloma, most patients will eventually relapse. With triplet and even quadruplet combination therapies becoming standard in the first and second line, many patients will have few treatment options...

Full description

Bibliographic Details
Main Authors: María-Victoria Mateos, Joan Bladé, Sara Bringhen, Enrique M Ocio, Yvonne Efebera, Luděk Pour, Francesca Gay, Pieter Sonneveld, Joachim Gullbo, Paul G. Richardson
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
melflufen
melphalan flufenamide
peptide–drug conjugate
multiple myeloma
new drugs
drug combinations
Online Access:https://www.mdpi.com/2077-0383/9/10/3120

Internet

https://www.mdpi.com/2077-0383/9/10/3120

Similar Items